Stock Events

Stock Events

China SXT Pharmaceuticals 

€0.04
0
+€0+0% Tuesday 07:06

Statistics

Day High
0.04
Day Low
0.04
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2RY1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
111
YI
Mkt Cap37.76M
111, Inc. operates a leading direct-to-patient digital healthcare platform in China, offering similar pharmaceutical products and services, thus competing in the same market space.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in China, directly competing in the pharmaceutical innovation and distribution sector.
HUTCHMED (China) Limited
HCM
Mkt Cap2.52B
Hutchison China MediTech Limited engages in the research, development, and commercialization of therapies in oncology and autoimmune diseases, competing for market share in China's pharmaceutical sector.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the healthcare and pharmaceutical market in China.
Can-Fite Biopharma
CANF
Mkt Cap15.35M
Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform aimed at addressing cancer, liver, and inflammatory diseases, competing in the pharmaceutical market.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, a multinational pharmaceutical company, offers a broad range of healthcare products that compete in the Chinese market, including innovative medicines and generics.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc., a global biopharmaceutical company, competes in China through its wide range of healthcare products, including vaccines, oncology, and internal medicine.

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Show more...
CEO
ISIN
VGG2161P1650
WKN
000A41YPR

Listings

XNAS
US
SXTC
BOATS
BOATS
SXTC.BOATS
F
DE
2RY1.F

0 Comments

Share your thoughts

FAQ

What is China SXT Pharmaceuticals stock price today?▼
The current price of 2RY1.F is €0.04 EUR — it has increased by +0% in the past 24 hours. Watch China SXT Pharmaceuticals stock price performance more closely on the chart.
What is China SXT Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange China SXT Pharmaceuticals stocks are traded under the ticker 2RY1.F.
When did China SXT Pharmaceuticals complete a stock split?▼
The last stock split for China SXT Pharmaceuticals was on February 03, 2026 with a ratio of 1:50.